These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 16857887

  • 21. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF, Diamond MP, Abuzeid M.
    Fertil Steril; 2010 Feb; 93(2):554-69. PubMed ID: 19362305
    [Abstract] [Full Text] [Related]

  • 22. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN.
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [Abstract] [Full Text] [Related]

  • 23. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial.
    Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Hum Reprod; 2006 Feb; 21(2):352-7. PubMed ID: 16269449
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 25. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP, Macklon NS, Fauser BC.
    J Clin Endocrinol Metab; 2003 Jan 01; 88(1):166-73. PubMed ID: 12519847
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists.
    Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Hum Reprod; 2004 Jul 01; 19(7):1525-9. PubMed ID: 15155603
    [Abstract] [Full Text] [Related]

  • 28. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J, Cholquevilque JL, Cela V, Martínez-Salazar J, Requena A, Garcia-Velasco JA.
    Fertil Steril; 2008 Dec 01; 90(6):2190-5. PubMed ID: 18191847
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
    Drakakis P, Loutradis D, Vomvolaki E, Stefanidis K, Kiapekou E, Anagnostou E, Anastasiadou K, Milingos S, Antsaklis A.
    Gynecol Endocrinol; 2007 Nov 01; 23(11):645-52. PubMed ID: 17999276
    [Abstract] [Full Text] [Related]

  • 31. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].
    Olivennes F.
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct 01; 33(6 Pt 2):3S24-6. PubMed ID: 15643682
    [Abstract] [Full Text] [Related]

  • 32. Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization.
    Kovacs P, Kovats T, Kaali SG.
    Fertil Steril; 2010 Feb 01; 93(2):475-9. PubMed ID: 19200991
    [Abstract] [Full Text] [Related]

  • 33. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations.
    Kaider AS, Coulam CB.
    Early Pregnancy (Cherry Hill); 2000 Jul 01; 4(3):191-9. PubMed ID: 11727011
    [Abstract] [Full Text] [Related]

  • 34. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep 01; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 35. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.
    Fertil Steril; 2013 Sep 01; 100(3):742-7. PubMed ID: 23806846
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
    Andersen AN, Devroey P, Arce JC.
    Hum Reprod; 2006 Dec 01; 21(12):3217-27. PubMed ID: 16873892
    [Abstract] [Full Text] [Related]

  • 37. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists.
    Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Hum Reprod; 2006 Apr 01; 21(4):1012-7. PubMed ID: 16339166
    [Abstract] [Full Text] [Related]

  • 38. Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.
    Merviel P, Antoine JM, Mathieu E, Millot F, Mandelbaum J, Uzan S.
    Fertil Steril; 2004 Jul 01; 82(1):119-25. PubMed ID: 15236999
    [Abstract] [Full Text] [Related]

  • 39. GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study.
    Kol S, Humaidan P, Itskovitz-Eldor J.
    Hum Reprod; 2011 Oct 01; 26(10):2874-7. PubMed ID: 21784738
    [Abstract] [Full Text] [Related]

  • 40. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
    Elassar A, Mann JS, Engmann L, Nulsen J, Benadiva C.
    Fertil Steril; 2011 Jan 01; 95(1):324-6. PubMed ID: 20797708
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.